Search
Search Results
##search.searchResults.foundPlural##
-
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1530PDF: 673HTML: 4208 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1341PDF: 671HTML: 6947 -
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
6027PDF: 1135HTML: 503TABLE: 251FIGURES: 347 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3781PDF: 1672HTML: 4588CoverLetter: 316Figure1: 330 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2398PDF: 1755HTML: 754 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1325PDF: 911HTML: 2211Figue 1: 220 -
-
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
2127PDF: 898HTML: 2240Table 1: 255Table 2: 259Table 3: 260Table 4: 255Table 5: 281Tble 6: 250Cover Letter: 274Greene Tab.7: 269 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
4001PDF: 1749HTML: 900Figures . Eliassian: 349 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3903PDF: 2691HTML: 1732 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2711PDF: 1437HTML: 1882CoverLetter: 253 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
2080PDF: 1276HTML: 359 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3600PDF: 1724HTML: 4105 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1896PDF: 700HTML: 316 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1397PDF: 1029HTML: 360 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2421PDF: 1731HTML: 778 -
-
-
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
5278PDF: 3051HTML: 2390 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
3090PDF: 1083HTML: 7534 -
-
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
5298PDF: 1404HTML: 1953Untitled: 253Untitled: 244 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2220PDF: 195HTML: 54







